期刊文献+

^(60)Coγ射线诱变阿维拉霉素筛选高产菌株及培养基优化 被引量:11

^(60)Co γ-IRRADIATION MUTATION INDUCTION FOR SCREENING OF AVILAMYCIN STRAINS WITH HIGH PRODUCTIVITY AND ITS CULTURE MEDIUM OPTIMIZATION
下载PDF
导出
摘要 用60Coγ射线对绿色产色链霉菌A-05菌株进行了诱变处理,以正突变率为标准确定诱变的适宜剂量为350 Gy。诱变后得到5株较高产突变菌株,其中H-15菌株经连续传代6次,遗传性状稳定,阿维拉霉素发酵单位达到68.5mg/L。采用响应面分析法对菌株H-15生产阿维拉霉素的发酵培养基碳氮源进行了优化设计。在所试验的碳氮源中,可溶性淀粉、核糖分别作为唯一碳源时,阿维拉霉素发酵单位较高,分别达82.67和79.45mg/L,乳糖、果糖、葡萄糖分别作为唯一碳源时菌株的效价较低;3%的豆粕粉和2%的大豆蛋白胨作为氮源时阿维拉霉素发酵单位分别为77.6和62.7mg/L。采用双碳源双氮源更有利于菌株提高阿维拉霉素的发酵单位,响应面分析结果表明,可溶性淀粉、核糖和大豆蛋白胨对阿维拉霉素发酵单位影响较显著。优化后的碳氮源组成为:可溶性淀粉20.12g/L,D-核糖7.81g/L,豆粕粉25.23g/L,大豆蛋白胨5.06g/L。优化后的模型计算出阿维拉霉素发酵单位由原来的71.63mg/L提高到101.48mg/L。 60^Coγ-irradiation was used for mutation treatment to screen high avilamycin production strains. Irradiation at 350Gy gave a positive mutation ratio at 26.5%. The derived mutant H-15 strain of Streptomyces viridoehrongenes showed high avilamycin productivity at 68.5mg/L. Then effects of different carbon and nitrogen sources on the producing strain H-15 were investigated by one factor test and optimized with Response Surface Methodology. The results indicated that the optimum carbon and nitrogen source were soluble starch 20.12g/L, ribose 7.81g/L, soy powder 25.23g/L and soy peptone 5.06g/L. Under those conditions, the predicted consistent value of avilamycins yield was 101.48mg/L, which was in consistent with the measured value.
出处 《核农学报》 CAS CSCD 北大核心 2007年第5期451-455,共5页 Journal of Nuclear Agricultural Sciences
关键词 链霉菌 60^Co诱变 阿维拉霉素 响应面分析法 Streptomyces viridoehrongenes y-irradiation induction avilamycins Response Surface Methodology
  • 相关文献

参考文献13

  • 1Wright D E. The orthosomycins, a new family of antibiotics. Tetrahedron, 1978, 35:1207 - 1237
  • 2Champney W S, Tober C L. Eveminomicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells, Antimlcrob. Agents Chemother,2000,44: 1413- 1417
  • 3Foster D R, Rybak M J. Pharmacologic and bacteriologic properties of SCH27899 ( Ziraein ), an investigational antibiotic from the eveminomiein family. Pharmacotherapy, 1999,19 : 1111 - 1117
  • 4Fuchs P C, Barry A L, et al. In vitro activities of SCH27899 alone and in combination with 17 other antimlcrobial agents. Antimicrob. Agents Chemother, 1999,43 : 2996 - 2997
  • 5欧盟决定延长阿维拉霉素的使用[J].中国动物保健,2003,5:41-41.
  • 6Chauvin C, Gicquel-Bruneau M, et al. Use of avilamycin for growth promotion and avilamycin-resistance among Enterococcus faecium from broilers in a matched case-control study in France. Preventive Veterinary Medicine, 2005, 70: 155- 163
  • 7http : www. ivdc. gov. cn ://8080/was40/search? channelid = 44500
  • 8朱传合,贺亚男,路福平,杜连祥.微波对阿维拉霉素产生菌诱变效应的研究[J].现代生物医学进展,2006,6(4):32-34. 被引量:11
  • 9朱传合,贺亚男,路福平,杜连祥.N^+离子注入阿维拉霉素产生菌诱变效应的研究[J].核技术,2006,29(8):609-613. 被引量:14
  • 10Weitnauer G, Muhlenweg A, et al. Biosynthesis of the orthosomycin antibiotic avilamycin A : deductions from the molecular analysis of the avi biosynthetic gene cluster of Streptomyces vifidochromogenes Tu' 57 and production of new antibiotics. Chemistry & Biology, 2001, 8 : 569 - 581

二级参考文献15

共引文献23

同被引文献151

引证文献11

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部